Thrombosis researchHumansPrimary MyelofibrosisNitrilesPyrazolesFibrinogen
Prothrombotic profiles in myelofibrosis: Fibrinogen oxidation and the beneficial effects of ruxolitinib.
Francesca Nencini, Enrico La Spina, Serena Borghi, Elvira Giurranna, Flavia Rita Argento, Eleonora Fini, Cesarina Giallongo, Andrea Duminuco, Giovanni Li Volti, Giuseppe Alberto Palumbo, Niccolò Taddei, Claudia Fiorillo, Daniele Tibullo, Matteo Becatti
Published: 202510.1016/j.thromres.2025.109517
Abstract
Myelofibrosis (MF) is a myeloproliferative neoplasm characterized by stem cell-derived clonal myeloproliferation, bone marrow fibrosis, extramedullary hematopoiesis and aberrant inflammation. About 90 % of MF patients carry mutations in JAK2, CALR, o…
Preview only. Read the full abstract at the source